IOVA•benzinga•
Iovance Biotherapeutics Publishes Final Analysis Of Phase 2 C-144-01 Clinical Trial Evaluating Individualized T Cell Therapy Amtagvi In Patients With Advanced Melanoma In Journal of Clinical Oncology.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 2, 2025 by benzinga